TotalSeq™-A1454 anti-human CD112R (PVRIG), CD112R, W16216D,BioLegend,301509

Host

Rat

Reactivity

Human

Application

PG – Quality tested

Platform ID

BAB891984959

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-A1454 anti-human CD112R (PVRIG), CD112R, W16216D
Cat. No.301509
HostRat
RRIDAB_3662385 (BioLegend Cat. No. 301509)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationPG – Quality tested
ClonalityMonoclonal
Clone NumberW16216D
Concentration0.5 mg/mL
TargetCD112R
ImmunogenHuman CD112R transfectants
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-A oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD112R gene encodes a single transmembrane protein consisting of a single extracellular IgV domain. Its long intracellular domain contains two tyrosine residues, one of which is within an ITIM-like motif. CD112R was initially named PVRIG for the homology observed between its second exon and the variable immunoglobulin domain of the polio virus receptor (PVR/CD155) and polio virus receptor-like (PVRL) genes. CD112R is a cell surface receptor for CD112/Nectin-2, it compete against CD226 in binding to CD112. Following interaction with CD112, CD112R inhibits T-cell proliferation and the disruption of interaction between CD112R and CD112 enhances T cell response. Published studies suggest that CD112R is a novel co-inhibitory receptor, or a checkpoint molecule, that suppressed TCR medicated signal.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.